F. Mulhaupt

发表

Reduced Connexin43 Expression Inhibits Atherosclerotic Lesion Formation in Low-Density Lipoprotein Receptor–Deficient Mice

F. Mach, M. Chanson, B. Kwak, 2003, Circulation.

PPAR (cid:1) but not PPAR (cid:2) Ligands Are Potent Repressors of Major Histocompatibility Complex Class II Induction in Atheroma-Associated Cells

F. Mach, N. Rufer, B. Kwak, 2002 .

The HMG-CoA reductase inhibitor simvastatin inhibits IFN-gamma induced MHC class II expression in human vascular endothelial cells.

F. Mach, B. Kwak, G. Pelli, 2001, Swiss medical weekly.

Statins as a newly recognized type of immunomodulator

F. Mach, B. Kwak, S. Myit, 2000, Nature Medicine.

PPAR&ggr; but not PPAR&agr; Ligands Are Potent Repressors of Major Histocompatibility Complex Class II Induction in Atheroma-Associated Cells

F. Mach, N. Rufer, B. Kwak, 2002 .

Structure-function analysis of the U2 snRNP-associated splicing factor SF3a.

A. Krämer, D. Nesic, G. Tanacković, 2005, Biochemical Society transactions.

Structure – function analysis of the U 2 snRNP-associated splicing factor SF 3 a

A. Krämer, D. Nesic, G. Tanacković, 2005 .

Statins (HMG-CoA reductase inhibitors) reduce CD40 expression in human vascular cells.

T. Lüscher, F. Mach, C. Matter, 2003, Cardiovascular research.

Antagonism of RANTES Receptors Reduces Atherosclerotic Plaque Formation in Mice

F. Mach, A. Proudfoot, B. Kwak, 2004, Circulation research.

Reduced Connexin 43 Expression Inhibits Atherosclerotic Lesion Formation in Low-Density Lipoprotein Receptor – Deficient Mice

F. Mach, M. Chanson, B. Kwak, 2003 .

Altered Pattern of Vascular Connexin Expression in Atherosclerotic Plaques

D. Gros, F. Mach, B. Kwak, 2002, Arteriosclerosis, thrombosis, and vascular biology.

The HMG-CoA reductase inhibitor simvastatin inhibits IFN-γ induced MHC class II expression in human vascular endothelial cells Statins as a potential novel immunosuppressive agent

F. Mach, B. Kwak, G. Pelli, 2001 .

Atherosclerosis: anti-inflammatory and immunomodulatory activities of statins.

F. Mach, B. Kwak, F. Mulhaupt, 2003, Autoimmunity reviews.

PPARgamma but not PPARalpha ligands are potent repressors of major histocompatibility complex class II induction in atheroma-associated cells.

F. Mach, N. Rufer, B. Kwak, 2002, Circulation research.